Morgan Stanley’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-151,885
Closed -$10.3M 6936
2019
Q3
$10.3M Buy
151,885
+40,139
+36% +$2.72M ﹤0.01% 2088
2019
Q2
$6.5M Buy
111,746
+52,687
+89% +$3.06M ﹤0.01% 2638
2019
Q1
$4.14M Sell
59,059
-48,713
-45% -$3.41M ﹤0.01% 2888
2018
Q4
$6.94M Buy
107,772
+58,920
+121% +$3.79M ﹤0.01% 2519
2018
Q3
$3.43M Sell
48,852
-7,992
-14% -$561K ﹤0.01% 3560
2018
Q2
$2.87M Sell
56,844
-36,262
-39% -$1.83M ﹤0.01% 3746
2018
Q1
$2.91M Sell
93,106
-26,717
-22% -$836K ﹤0.01% 3628
2017
Q4
$4.1M Sell
119,823
-15,742
-12% -$538K ﹤0.01% 3317
2017
Q3
$4.35M Buy
135,565
+81,623
+151% +$2.62M ﹤0.01% 3106
2017
Q2
$1.76M Sell
53,942
-17,796
-25% -$579K ﹤0.01% 3914
2017
Q1
$2.26M Sell
71,738
-93,504
-57% -$2.94M ﹤0.01% 3701
2016
Q4
$4.86M Buy
165,242
+104,778
+173% +$3.08M ﹤0.01% 3024
2016
Q3
$1.75M Sell
60,464
-44,572
-42% -$1.29M ﹤0.01% 3597
2016
Q2
$2.72M Buy
105,036
+1,582
+2% +$41K ﹤0.01% 3164
2016
Q1
$2.56M Sell
103,454
-11,980
-10% -$297K ﹤0.01% 3146
2015
Q4
$4.06M Sell
115,434
-91,052
-44% -$3.21M ﹤0.01% 2875
2015
Q3
$4.37M Buy
206,486
+75,659
+58% +$1.6M ﹤0.01% 2775
2015
Q2
$3.64M Buy
130,827
+24,204
+23% +$673K ﹤0.01% 3082
2015
Q1
$3.26M Sell
106,623
-53,451
-33% -$1.63M ﹤0.01% 3145
2014
Q4
$5.12M Buy
160,074
+49,966
+45% +$1.6M ﹤0.01% 2719
2014
Q3
$3.12M Buy
110,108
+8,416
+8% +$238K ﹤0.01% 3067
2014
Q2
$2.79M Buy
101,692
+27,658
+37% +$758K ﹤0.01% 3221
2014
Q1
$1.95M Sell
74,034
-83,645
-53% -$2.2M ﹤0.01% 3440
2013
Q4
$4.62M Buy
157,679
+80,330
+104% +$2.35M ﹤0.01% 2640
2013
Q3
$2.37M Sell
77,349
-66,499
-46% -$2.03M ﹤0.01% 3091
2013
Q2
$4.56M Buy
+143,848
New +$4.56M ﹤0.01% 2418